Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis

Abstract

We concluded that IPF patients with a mild disease, diagnosis by SLB, or both showed indications of a good response to pirfenidone. In addition, acid-secretion inhibitors may reduce the frequency of anorexia, nausea, or both from pirfenidone.